dr reddys laboratories
Fujifilm & Dr. Reddy’s Call Off Generic Drugs Joint Venture In Japan
FUJIFILM and Dr. Reddy’s Laboratories have terminated an MOU to enter into a joint venture for the Japanese generics drugs market.
Dr. Reddy’s Initiates Phase II Study With CETP Inhibitor, DRL-17822
Dr. Reddy’s Laboratories announced this week the initiation of a Phase II study of DRL-17822 in patients with diagnosis of type II dyslipidemia.
Dr. Reddy’s Acquires Russian Portfolio From JB Chemicals & Pharmaceuticals
Dr. Reddy’s Laboratories announced on Friday that it will acquire the prescription portfolio of JB Chemicals & Pharmaceuticals in Russia and other CIS regions.
